Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia?
Sheppard Pratt Health System, Baltimore, Maryland, Associate Professor, Department of Psychiatry and Behavioral Sciences, George Washington University, School of Medicine and Health Sciences, Washington, DC.
Maju Mathew
MM
Koola
Emeritus Professor, Department of Surgery, University of Miami, Miami, Florida, Department of Surgery, Harvard Medical School, Cambridge, Massachusetts.
Jeffrey K
JK
Raines
Professor, Departments of Medicine and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Robert G
RG
Hamilton
Professor of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland.
Robert P
RP
McMahon
anti-inflammatory medications; arterial compliance; cytokines; inflammation; mortality; schizophrenia; symptoms